The GABA agonist THIP, attenuates antinociception in the mouse by modifying central cholinergic transmission

Neuropharmacology. 1987 May;26(5):433-7. doi: 10.1016/0028-3908(87)90023-2.

Abstract

The effect of THIP, a direct-acting gamma-aminobutyric acid (GABA) receptor agonist, on the antinociceptive response to a variety of agents was examined using the mouse tail-immersion assay. Alone, THIP produced an antinociceptive response in smaller doses (5 mg/kg) but was ineffective at doses exceeding 10 mg/kg. Treatment with THIP (15 mg/kg) was found to block the antinociceptive response to an inhibitor of the uptake of GABA, an inhibitor of GABA-transaminase, a direct-acting GABA receptor agonist and to a cholinesterase inhibitor. In contrast, THIP had no effect on the antinociceptive responses to morphine, clonidine or oxotremorine. The results indicate that large doses of THIP reduce cholinergic activity in a pathway important for mediating the antinociceptive action of GABAergic drugs and physostigmine.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Afferent Pathways / drug effects
  • Analgesics / antagonists & inhibitors*
  • Analgesics / pharmacology
  • Animals
  • Central Nervous System / drug effects*
  • Cholinergic Fibers / drug effects
  • GABA Antagonists
  • Isoxazoles / pharmacology*
  • Male
  • Mice
  • Oxazoles / pharmacology*
  • Pain / drug therapy
  • Pain / physiopathology*
  • Physostigmine / antagonists & inhibitors
  • Synaptic Transmission / drug effects

Substances

  • Analgesics
  • GABA Antagonists
  • Isoxazoles
  • Oxazoles
  • Physostigmine
  • gaboxadol